Advertisement

Keywords

Contrast Agent Contrast Medium Pediatric Radiology Sodium Iodide Nonionic Contrast Medium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Swick, M (1978) Radiographic media in urology, the discovery of excretion urography. Surgical Clinics of North America 58: 977–994PubMedGoogle Scholar
  2. 2.
    Grainger RG, Thomas AMK (1999) History of the development of radiological contrast agents (1895–1996). In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. Pp3–14Google Scholar
  3. 3.
    Cameron D (1917) Aqueous solutions of potassium & sodium iodides as opaque media in roentgenography. J American Medical Association 70: 754–755Google Scholar
  4. 4.
    Osborne ED, Sutherland CG, Scholl AJ Jr, Rowntree LG (1923) Roentgenology of the urinary tract during excretion of sodium iodide. American Medical Association 80: 368–373Google Scholar
  5. 5.
    Swick M (1929) Darstellung der Niere und Harnwege in Roentgenbild durch intravenöse Einbringung eines neuen Kontraststoffes: des Uroselectans. Klinische Wochenschrift 8: 2087–2089CrossRefGoogle Scholar
  6. 6.
    Von Lichtenberg A, Swick M (1929) Klinische Prüfung des Uroselectans. Klinische Wochenschrift 8: 2089–2091CrossRefGoogle Scholar
  7. 7.
    Wallingford VH (1953) The development of organic iodide compounds as X-ray contrast media. Journal of American Pharmacological Association (Scientific Edition) 42: 721–728Google Scholar
  8. 8.
    Hoppe JO, Larsen HA, Coulston FJ (1956) Observations on the toxicity of a new urographic contrast medium, sodium 3,5-diacetamido-2, 4, 6 tri-iodobenzoate (Hypaque sodium) and related compounds. Journal of Pharmacological and Experimental Therapeutics 116: 394–403Google Scholar
  9. 9.
    Grainger RG (1982) Intravascular contrast media — the past, the present and the future. British Journal of Radiology 55: 1–18PubMedGoogle Scholar
  10. 10.
    Almén T (1969) Contrast agent design. Some aspects on the synthesis of water-soluble contrast agents of low osmolality. Journal of Theoretical Biology 24: 216–226PubMedGoogle Scholar
  11. 11.
    Amdam RP, Sogner K (1994) Wealth of contrasts. Oslo: Ad Notam GyldendalGoogle Scholar
  12. 12.
    Dawson P, Grainger RG, Pitfield J (1983) The new low-osmolar contrast media: a simple guide. Clinical Radiology 34: 221–226CrossRefPubMedGoogle Scholar
  13. 13.
    Dawson P, Saini S, Schild H, Niendorf HP, Schlieff R (1994) Continuing progress in contrast agents. Imaging 6: 273–284Google Scholar
  14. 14.
    Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ (2003) Nephrotoxic effects in high-risk patients undergoing angiography. New England Journal of Medicine 348: 491–499CrossRefPubMedGoogle Scholar
  15. 15.
    Almén T (1985) Development of non-ionic contrast media. Investigative Radiology 20: 2–9PubMedGoogle Scholar
  16. 1.
    Weinmann HJ (1999) Gadolinium chelates: physico-chemical properties, formulation and toxicology. In: Dawson P, Cosgrove DO, Grainger RG. Textbook of Contrast Media. Isis, Oxford. pp 297–318Google Scholar
  17. 2.
    Lauterbur PC, Mendonça-Dias H, Rudin AM (1978) Augmentation of tissue proton spin-lattice relaxation rates by in vivo addition of paramagnetic ions. in: Dutton PO, Leigh J, Scarpa A (eds). Frontiers of Biological Energetics. New York: Academic Press pp 752–759Google Scholar
  18. 3.
    Haën C (2001) Conception of the first magnetic resonance imaging contrast agents: a brief history. Topics in Magnetic Resonance Imaging 12: 221–230CrossRefPubMedGoogle Scholar
  19. 4.
    Carr D, Brown I, Bydder G, Weinmann HJ, Speck U, Thomas DJ, Young IR (1984) Intravenous chelated gadolinium as a contrast agent in NMR imaging of cerebral tumours. Lancet i: 484–486CrossRefGoogle Scholar
  20. 5.
    Weinmann HJ, Brasch RC, Press WR, Wesby GE (1984) Characteristics of gadolinium-DT-PA complex: a potential NMR contrast agent. AJR 142: 619–624PubMedGoogle Scholar
  21. 6.
    Brasch RC, Weinmann HJ, Wesbey GE (1984) Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. Am J Roentgenology 142: 625–630Google Scholar
  22. 7.
    Claussen C, Laniado M, Schörner W, et al. (1985) Gadolinium-DTPA in MR imaging of glioblastomas and intracranial metastases. Am J Neuroradiol 6: 669–674PubMedGoogle Scholar
  23. 8.
    Weinmann HJ (2003) History of MRI contrast media development, accompanied by Magnevist. 15 years of Magnevist, Satellite Symposium: ECR 2003Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Personalised recommendations